
Benfotiamine
Chemical Name: Benfotiamine (S-benzoylthiamine O-monophosphate) CAS Number: 22457-89-2 Molecular Formula: C₁₉H₂₃N₄O₆PS Molecular Weight: 466.45 g/mol Therapeutic Uses: Diabetic neuropathy, neuroprotection, nerve &
Fenofibrate is also known as lipid modifying agent widely used for the treatment of hyperlipidemia and hypertriglyceridemia and promotes cardiovascular protection through multiple metabolic pathways. Fenofibrate activates peroxisome proliferator activated receptor alpha [PPARα] which is nuclear receptor that regulates lipid metabolism. Fenofibrate increases overall cardiovascular health and decreases fibrinogen, C-reactive protein as well as uric acid levels.
Fenofibrate has broad efficacy and well tolerance level which shows targeted action resulting in low triglyceride levels. It provides long term lipid management and therefore is widely used in oral solid dosage forms such as tablets and capsules.
Chemox Pharma supplies pharma grade Fenofibrate API which helps in development of innovative formulations for effective cardiovascular wellness and good lipid control that results in empowering the fight against dyslipidaemia and overall metabolic and vascular health. Chemox Pharma offers consistent high-quality API and follow WHO-GMP regulated standards.
| Sr. No. | Description | Application |
|---|---|---|
| 1 | Lipid-lowering API | Dyslipidemia formulations |
| 2 | Fibric acid derivative drug substance | Hypertriglyceridemia therapy |
| 3 | Cardiovascular therapeutic ingredient | Cholesterol reduction drugs |
| 4 | PPAR-α agonist pharmaceutical API | Mixed dyslipidemia treatment |
| 5 | Antihyperlipidemic API | Atherosclerosis risk reduction |
Fenofibrate is widely used by pharmaceutical manufacturers in oral lipid-lowering formulations for cholesterol and triglyceride management.
Fenofibrate API should be handled according to standard pharmaceutical material safety and industrial hygiene procedures. Appropriate protective measures must be followed during handling and processing of the cardiovascular active pharmaceutical ingredient in GMP manufacturing environments.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of powder and contact with skin or eyes
Handle in controlled pharmaceutical manufacturing areas
Follow GMP material handling procedures
Refer to Safety Data Sheet (SDS) for detailed safety guidance
This API is intended exclusively for pharmaceutical manufacturing and formulation use.
Fenofibrate is a fibric acid derivative that activates peroxisome proliferator-activated receptor alpha (PPAR-α). Activation of PPAR-α enhances lipoprotein lipase activity, increases fatty acid oxidation, and reduces hepatic triglyceride production. This leads to decreased triglycerides, reduced LDL cholesterol, and increased HDL cholesterol, improving lipid profiles in dyslipidemia patients.
Handle in approved pharmaceutical manufacturing facilities
Avoid exposure without protective equipment
Prevent dust generation and inhalation
Follow GMP containment procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain controlled room temperature
Keep in designated API storage areas
Follow GMP warehouse practices
Fenofibrate API is used in pharmaceutical formulations for the treatment of dyslipidemia and hypertriglyceridemia to reduce cholesterol and triglyceride levels.
Yes, Chemox Pharma is a WHO-GMP certified Fenofibrate API manufacturer and supplier in India serving global pharmaceutical companies.
The CAS number of Fenofibrate API is 49562-28-9.
Fenofibrate belongs to the fibric acid derivative (PPAR-α agonist) class of lipid-lowering agents used in cholesterol and triglyceride management.
It should be stored in tightly closed containers at controlled room temperature, protected from moisture and light, following pharmaceutical storage guidelines.

Chemical Name: Benfotiamine (S-benzoylthiamine O-monophosphate) CAS Number: 22457-89-2 Molecular Formula: C₁₉H₂₃N₄O₆PS Molecular Weight: 466.45 g/mol Therapeutic Uses: Diabetic neuropathy, neuroprotection, nerve &

API name/end use: Sartan family Cas number: 124750-51-2 Molecular formula: C33H25BrN4 Molecular Weight: 557.48 Appearance: Solid Powder Storage: Room Temperature (Recommended in

API name/end use: Tadalafil Cas number: 14907-27-8 Molecular formula: C12H14N2O2·HCl Molecular Weight: 254.71 Appearance: Solid Powder Storage: Room Temperature (Recommended in a